Showing results (221-230 of 320) with videos related to
Sort By:
Pageof 32
British Journal of Cancer|September 4, 2025
Inhibition of YB-1 phosphorylation enhances cisplatin activity and disrupts cell division in pleural mesotheliomaKarin Schelch, Nadine Maach, Muhammad Hashim, et al.Molecular Cancer Therapeutics|August 2, 2014
Calpain-mediated integrin deregulation as a novel mode of action for the anticancer gallium compound KP46Ute Jungwirth, Johannes Gojo, Theresa Tuder, et al.Molecular Cancer Therapeutics|January 24, 2015
Vemurafenib resistance signature by proteome analysis offers new strategies and rational therapeutic conceptsVerena Paulitschke, Walter Berger, Philipp Paulitschke, et al.Journal of the American Chemical Society|February 24, 2025
Leveraging Immunogenic Cell Death to Enhance the Immune Response against Malignant Pleural Mesothelioma TumorsMeng Rui Chang, Egor M Matnurov, Chengnan Wu, et al.Oncotarget|March 8, 2016
High circulating activin A level is associated with tumor progression and predicts poor prognosis in lung adenocarcinomaMir Alireza Hoda, Anita Rozsas, Elisabeth Lang, et al.Cytotherapy|April 13, 2019
Spheroid glioblastoma culture conditions as antigen source for dendritic cell-based immunotherapy: spheroid proteins are survival-relevant targets but can impair immunogenic interferon γ productionFriedrich Erhart, Tamara Weiss, Simone Klingenbrunner, et al.Molecular Pharmacology|February 15, 2012
Anticancer activity of methyl-substituted oxaliplatin analogsUte Jungwirth, Dimitris N Xanthos, Johannes Gojo, et al.Journal of Experimental & Clinical Cancer Research : CR|September 9, 2017
Intrinsic fluorescence of the clinically approved multikinase inhibitor nintedanib reveals lysosomal sequestration as resistance mechanism in FGFR-driven lung cancerBernhard Englinger, Sebastian Kallus, Julia Senkiv, et al.Annals of Surgery|July 4, 2012
Pretreatment serum C-reactive protein levels predict benefit from multimodality treatment including radical surgery in malignant pleural mesothelioma: a retrospective multicenter analysisBahil Ghanim, Mir Alireza Hoda, Max-Paul Winter, et al.Antioxidants (Basel, Switzerland)|January 28, 2026
Reactive Oxygen Species Drive Cell Migration and PD-L1 Expression via YB-1 Phosphorylation in Pleural MesotheliomaMuhammad Hashim, Gerald Timelthaler, Dominik Kirchhofer, et al.Pageof 32